Literature DB >> 19347018

Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.

Chih-Ping Han1, Lai-Fong Kok, Po-Hui Wang, Tina S Wu, Yeu-Sheng Tyan, Ya-Wen Cheng, Ming-Yung Lee, Shun-Fa Yang.   

Abstract

Endocervical adenocarcinomas and endometrial adenocarcinomas are malignancies that affect uterus; however, their biological behaviors are quite different. This distinction has clinical significance, because the appropriate therapy may depend on the site of tumor origin. The purpose of this study is to evaluate four different scoring methods of p16(INK4a) immunohistochemical staining in distinguishing between primary endocervical adenocarcinomas and endometrial adenocarcinomas from limited sizes of tissue specimens. A tissue microarray was constructed using formalin-fixed, paraffin-embedded tissue from hysterectomy specimens, including 14 endocervical adenocarcinomas and 21 endometrial adenocarcinomas. Tissue array sections were immunostained with a commercially available antibody of p16(INK4a). Avidin-biotin complex method was used for antigens visualization. The staining intensity and area extent of the immunohistochemistry was evaluated using the semiquantitative scoring system. Of the four scoring methods for p16(INK4a) expression, Method Nucleus, Method Dominant Cytoplasm or Nucleus, and Method Mean of Cytoplasm plus Nucleus showed significant (P values <0.05), but Method Cytoplasm did not show significant (P=0.432), frequency distinction between endocervical adenocarcinomas and endometrial adenocarcinomas. In addition, Method Mean of Cytoplasm plus Nucleus had the highest overall accuracy rate (80%) for diagnostic distinction among these four score-counting methods. According to the data in this tissue microarray study, Method Nucleus is the most convenient and efficient method to distinguish between endocervical adenocarcinomas and endometrial adenocarcinomas. Although Method Dominant Cytoplasm or Nucleus as well as Method Mean of Cytoplasm plus Nucleus also revealed statistically significant results, they are relatively more inconvenient due to complicated score calculating means on the basis of mixed cytoplasmic and nuclear p16(INK4a) expressions. Method Cytoplasm is of no use in the diagnostic distinction between endocervical adenocarcinomas and endometrial adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347018     DOI: 10.1038/modpathol.2009.31

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  24 in total

1.  Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

Authors:  Xuetian Yue; Zhenyu Zhang; Xiaohong Liang; Lifen Gao; Xiaoning Zhang; Di Zhao; Xiao Liu; Hongxin Ma; Min Guo; Brett T Spear; Yaoqin Gong; Chunhong Ma
Journal:  Gastroenterology       Date:  2012-03-06       Impact factor: 22.682

2.  Significance of p53 expression in background endometrium in endometrial carcinoma.

Authors:  Thuy Thi Nguyen; Toru Hachisuga; Rie Urabe; Tomoko Kurita; Seiji Kagami; Toshinori Kawagoe; Shohei Shimajiri; Kazuki Nabeshima
Journal:  Virchows Arch       Date:  2015-03-19       Impact factor: 4.064

3.  VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.

Authors:  Jing Zhang; Tao Wu; Jeremy Simon; Mamoru Takada; Ryoichi Saito; Cheng Fan; Xian-De Liu; Eric Jonasch; Ling Xie; Xian Chen; Xiaosai Yao; Bin Tean Teh; Patrick Tan; Xingnan Zheng; Mingjie Li; Cortney Lawrence; Jie Fan; Jiang Geng; Xijuan Liu; Lianxin Hu; Jun Wang; Chengheng Liao; Kai Hong; Giada Zurlo; Joel S Parker; J Todd Auman; Charles M Perou; W Kimryn Rathmell; William Y Kim; Marc W Kirschner; William G Kaelin; Albert S Baldwin; Qing Zhang
Journal:  Science       Date:  2018-07-20       Impact factor: 47.728

4.  Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation.

Authors:  Shun Yao; Hsin-Yi Huang; Xiangkun Han; Yi Ye; Zhen Qin; Gaoxiang Zhao; Fuming Li; Guohong Hu; Liang Hu; Hongbin Ji
Journal:  Oncogene       Date:  2019-07-18       Impact factor: 9.867

5.  Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?

Authors:  Chiung-Ling Liao; Jeng-Dong Hsu; Ming-Yung Lee; Lai-Fong Kok; Yi-Ju Li; Po-Hui Wang; Chung-Chin Yao; Chih-Ping Han
Journal:  Virchows Arch       Date:  2010-03-11       Impact factor: 4.064

6.  High-risk HPV E6/E7 mRNA in situ hybridization in endocervical glandular neoplasia: performance compared with p16INK4a and Ki67 immunochemistry.

Authors:  Tingting Chen; Jing Li; Shunni Wang; Yan Ning; Xianrong Zhou; Yiqin Wang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

7.  Identification and Defensive Characterization of PmCYP720B11v2 from Pinus massoniana.

Authors:  Bin Liu; Yini Xie; Huanhuan Yin; Zhichun Zhou; Qinghua Liu
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

8.  Antitumoral effects of Allium sivasicum on breast cancer in vitro and in vivo.

Authors:  Bektas Tepe; Ersin Tuncer; Serpil Unver Saraydın; Hatice Ozer; Metin Sen; Kursat Karadayi; Deniz Sahin Inan; Sule Karadayi; Zübeyde Polat; Askin Akpulat; Mustafa Duman; Binnur Koksal; Mustafa Turan
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

9.  Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Authors:  Teng Hou; Dongxia Liang; Jiehua He; Xu Chen; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

10.  p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.

Authors:  Chih-Ping Han; Ming-Yung Lee; Yeu-Sheng Tyan; Lai-Fong Kok; Chung-Chin Yao; Po-Hui Wang; Jeng-Dong Hsu; Szu-Wen Tseng
Journal:  Virchows Arch       Date:  2009-09-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.